Carcinoma de pulmón como disparador de una respuesta autoinmune: un desafío médico

Sener, 2015, Serodetection of Antinuclear Antibodies (ANA) in Patients with Various Cancer Types, JMMR., 3, 15 Hashefi, 2018, The relationship between rheumatologic disorders and malignancies, Rheum Dis Clin North Am., 44, 405, 10.1016/j.rdc.2018.03.003 Giat, 2017, Cancer and autoimmune diseases, Autoimmun Rev., 16, 1049, 10.1016/j.autrev.2017.07.022 Manger, 2018, Rheumatic paraneoplastic syndromes - A clinical link between malignancy and autoimmunity, Clin Immunol., 186, 67, 10.1016/j.clim.2017.07.021 Timis, 2012, Paraneoplastic syndromes with connective tissue involvemen“It's not always lupus!”. t, J BUON., 17, 417 Solans-Laqué, 2008, Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases, J Rheumatol., 35, 294 Pelosof, 2010, Paraneoplastic syndromes: an approach to diagnosis and treatment, Mayo Clin Proc., 85, 838, 10.4065/mcp.2010.0099 West, 2013, Pulmonary-renal syndrome: a life threatening but treatable condition, Postgrad Med J, 89, 274, 10.1136/postgradmedj-2012-131416 Sanders, 2011, Pulmonary: renal syndrome with a focus on anti-GBM disease, Semin Respir Crit Care Med., 32, 328, 10.1055/s-0031-1279829 Badsha, 2004, Pulmonary hemorrhage in systemic lupus erythematosus, Semin Arthritis Rheum., 33, 414, 10.1016/j.semarthrit.2003.09.006 Martínez-Martínez, 2014, Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage, J Rheumatol., 41, 1656, 10.3899/jrheum.130927 Specks, 2001, Diffuse alveolar hemorrhage syndromes, Curr Opin Rheumatol., 13, 12, 10.1097/00002281-200101000-00003 Kanaji, 2014, Paraneoplastic syndromes associated with lung cancer, World J Clin Oncol., 5, 197, 10.5306/wjco.v5.i3.197 Spiro, 2007, Physicians ACoC. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2.nd edition), Chest, 132 Patel, 1993, Paraneoplastic syndromes associated with lung cancer, Mayo Clin Proc., 68, 278, 10.1016/S0025-6196(12)60050-0 Nathanson, 1997, Introduction: paraneoplastic syndromes, Semin Oncol., 24, 265 Carsons, 1997, The association of malignancy with rheumatic and connective tissue diseases, Semin Oncol., 24, 360 Naschitz, 1995, Rheumatic manifestations of occult cancer, Cancer., 75, 2954, 10.1002/1097-0142(19950615)75:12<2954::AID-CNCR2820751224>3.0.CO;2-8 Chakravarty, 2003, Rheumatic syndromes associated with malignancy, Curr Opin Rheumatol., 15, 35, 10.1097/00002281-200301000-00007 Lien, 2011, Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis, Nat Rev Nephrol., 7, 85, 10.1038/nrneph.2010.171 Bacchetta, 2009, Paraneoplastic glomerular diseases and malignancies, Crit Rev Oncol Hematol., 70, 39, 10.1016/j.critrevonc.2008.08.003 Petri, 2012, Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum., 64, 2677, 10.1002/art.34473 Vlagea, 2018, Antinuclear antibodies and cancer: A literature review, Crit Rev Oncol Hematol., 127, 42, 10.1016/j.critrevonc.2018.05.002 Solans-Laqué, 2004, Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes, Lupus., 13, 159, 10.1191/0961203304lu521oa Wu, 2016, Systemic lupus erythematous increased lung cancer risk: Evidence from a meta-analysis, J Cancer Res Ther., 12, 721, 10.4103/0973-1482.172115 Bin, 2007, Lung cancer in systemic lupus erythematosus, Lung Cancer., 56, 303, 10.1016/j.lungcan.2007.01.007 Tsao, 2002, An update on genetic studies of systemic lupus erythematosus, Curr Rheumatol Rep., 4, 359, 10.1007/s11926-002-0046-5 Harley, 1998, The genetics of human systemic lupus erythematosus, Curr Opin Immunol., 10, 690, 10.1016/S0952-7915(98)80090-3